Form 4: MetLife CEO Michel Khalaf Executes Stock Options and Sells Shares
SEC Form 4 Filing
MetLife's CEO, Michel Khalaf, exercised stock options and sold a portion of the acquired shares to cover costs and taxes on December 13, 2024.
Summary
- MetLife CEO Michel Khalaf exercised 26,138 stock options at a price of $45.91 per share on December 13, 2024.
- He then sold 20,926 of these shares on the open market at a weighted average price of $82.8445 per share.
- The sales were executed to cover the exercise price of the options, related tax obligations, and fees.
- The remaining 5,212 shares were retained by Mr. Khalaf, bringing his total direct holdings to 500,799 shares.
- The stock options were part of an employee stock option plan and became exercisable in installments starting in 2016.
Sentiment
Score: 5
Explanation: The document is a routine SEC filing related to executive stock transactions, which is neither positive nor negative for the company's overall outlook.
Industry Context
This is a routine filing related to executive compensation and is common for publicly traded companies. It reflects the CEO's personal financial transactions and is not indicative of the company's overall performance or strategy.
Comparison to Industry Standards
- Executive stock option exercises and sales are a standard practice in publicly traded companies, particularly in the financial services sector.
- The timing and volume of these transactions are often dictated by vesting schedules and personal financial planning.
- Comparable companies such as Prudential Financial, AIG, and Lincoln National also have similar executive compensation structures that include stock options.
- The sale price of $82.8445 per share is within the typical range for MetLife's stock price at the time of the transaction.
Stakeholder Impact
- The transaction has a minimal impact on shareholders as it is a routine executive stock transaction.
- The sale of shares by the CEO does not indicate any change in the company's performance or outlook.
Key Dates
| Date | Description |
|---|---|
| 02/24/2016 | First installment of stock options became exercisable. |
| 02/24/2017 | Second installment of stock options became exercisable. |
| 02/27/2018 | Third installment of stock options became exercisable. |
| 12/13/2024 | Date of stock option exercise and share sale. |
| 12/17/2024 | Date of SEC Form 4 filing. |
| 02/23/2025 | Expiration date of the stock options. |
Keywords
MetLife, Michel Khalaf, stock options, insider trading, SEC Form 4, executive compensation, share sale
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.